Radiation induces rapid bone loss and enhances bone resorption and RANKL expression. 41 RANKL provides the crucial signal to induce osteoclast differentiation and plays an 42 important role in bone resorption. However, the mechanisms of radiation-induced 43 osteoporosis are not fully understood. Here, we show that Crif1 expression increases in bone 44 marrow cells after radiation. Conditional Crif1 deletion in bone marrow cells causes 45 decreases in RANKL expression and the RANKL/OPG ratio, and relieves bone loss after 46 radiation in mice. We further demonstrated in vitro that Crif1 promotes RANKL secretion via 47 the cAMP/PKA pathway. Moreover, protein-protein docking screening identified five 48 compounds as Crif1 inhibitors; these compounds dramatically suppressed RANKL secretion 49
after 7 days of coculture ( Figures 4J and 4K ). These results further demonstrated that Crif1 182 can regulate RANKL expression, especially after radiation. 184 To determine whether Crif1 affects RANKL expression in adipocytes, BM-MSCs were 194 Crif1 promotes RANKL secretion by modulating the cAMP/PKA signalling pathway 195 To verify the mechanism underlying Crif1-mediated upregulation of RANKL expression, 196 PKA agonist (forskolin) and inhibitor (H89) were added to the coculture system. Although Figures 6M and 6N ). After the 205 addition of forskolin, CREB phosphorylation was significantly increased in the control 206 BM-MSCs, but was dramatically inhibited in Crif1 knockout BM-MCSs ( Figure 6O ). We 207 also observed that CREB phosphorylation was suppressed in both Crif1-overexpressing 208 BM-MSCs and controls following exposure to H89 ( Figure 6P ). These results demonstrated 209 that Crif1 promotes RANKL expression through cAMP/PKA signalling pathway. 211 We used ClusPro and InterProSurf to investigate the interface in Crif1-PKAα complex, and 212 results showed that Thr 197 , Gly 200 , Thr 201 , Glu 203 , and Phe 129 of PKAα interact with Ile 132 , 213 Met 128 , Ile 121 , His 120 , and Arg 117 in the long alpha helical region of Crif1, forming the binding 214 interface ( Figure 7A ). A virtual screening using 462,608 compounds from the Life Chemicals 215 database around His 120 of Crif1 was carried out using the program Autodock_vina. A set of 216 13 compounds was selected for experimental screening based on binding energy <-12.0 217 kcal/mol (Table S1 ). Initially a tetrazolium salt (WST-8) assay was carried out to study 218 potential toxic effects of these compounds on hBM-MSCs, vero cells and mouse BM-MSCs 219 (Figures S1-S3). The compounds F0382-0033, F3408-0076, F1430-0134, F3408-0031 and 220 F1430-0130 showed low toxicity to hBM-MSCs at concentrations of 25 μM ( Figure 7G-7K ).
183

Crif1 mediates adipogenesis and RANKL secretion in adipocytes
210
Crif1 inhibitors effectively suppress RANKL secretion and CREB phosphorylation
221
The binding pattern in these ligand−protein complexes potentially contained multiple Figure 7M ). Moreover, RANKL/OPG ratios were also decreased by these 5 inhibitors 228 ( Figure 7N ). To further understand the mechanism, CREB phosphorylation was detected.
229
Western blotting analysis showed that CREB phosphorylation was inhibited by treatment 230 with the 5 inhibitors that showed suppressive effects on RANKL expression ( Figure 7O ). Table S1 . 13 compounds were chosen based on binding energy <-12.0 kcal/mol. 
